Donanemab, developed by Lilly, a monoclonal antibody targeting beta-amyloid, met its primary endpoint in a Phase 2 clinical trial, slowing clinical progression by 32% in patients with early-stage Alzheimer's disease
This guide explains the peptide reconstitution math, walks through the specific calculations for the most common Durham Peptides catalog items, and shows how to use the free Durham Peptides peptide calculator to handle the arithmetic quickly
What the research actually covers Characterised as the first selective compound of its class (Raun et al., 1998) Comparatively little effect on cortisol and prolactin No human trials measure whether it builds muscle or improves strength Mechanism is well described
The plasma half-life of GIP is less than 10 minutes in normal healthy adults
doi:10.1021/acs.jmedchem.1c01856
Feb 10, 2026 You are staring at a vial of white powder